specificity cas9 Search Results


90
BioMimetic Therapeutics lnps loaded with crispr-cas9 rnp complex
Nanofiber systems used for the delivery of polynucleotides.
Lnps Loaded With Crispr Cas9 Rnp Complex, supplied by BioMimetic Therapeutics, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9/cell+type+specific+crispr+cas9+delivery+by+biomimetic+metal+organic+frameworks/pmc09368923-48-2-9
Average 90 stars, based on 1 article reviews
lnps loaded with crispr-cas9 rnp complex - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

90
BlueGene Biotech cysteine aspartate-specific protease-9 ( cas-9 )
The relationship between relative expression of apoptotic genes and days of luxation ( BAX , Bcl-2-associated X protein; BCL-2 , B-cell lymphoma-2; CAS-3 cysteine aspartate-specific protease-3; CAS-9 , cysteine aspartate-specific <t>protease-9).</t>
Cysteine Aspartate Specific Protease 9 ( Cas 9 ), supplied by BlueGene Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/specificity+cas9/cysteine+aspartate+specific+protease+9+++cas+9++/pmc03806380-50-55-61
Average 90 stars, based on 1 article reviews
cysteine aspartate-specific protease-9 ( cas-9 ) - by Bioz Stars, 2026-10
90/100 stars
  Buy from Supplier

Image Search Results


Nanofiber systems used for the delivery of polynucleotides.

Journal: International Journal of Molecular Sciences

Article Title: Nanofiber Carriers of Therapeutic Load: Current Trends

doi: 10.3390/ijms23158581

Figure Lengend Snippet: Nanofiber systems used for the delivery of polynucleotides.

Article Snippet: PCL , LNPs loaded with CRISPR-Cas9 RNP complex , Biomimetic MSCM coating CXCL12 chimokine , Single nozzle electrospinning , Fragmented nanofibrils with biomimetic coating , Intra bone-marrow injection , Reduced human leukemic burden in mice , [ ] .

Techniques: In Vitro, In Vivo, Transfection, Virus, Plasmid Preparation, CRISPR, Injection

Injectable biomimetic nanofiber formulation for acute myeloid leukemia treatment: ( 1 ) PCL nanofibril coated with mesenchymal stem cell membrane (MSCM) loaded with cytokine CXCL12α and lipid nanoparticles-CRISPR/Cas9 (LNP-Cas9) complex. ( 2 ) Images of naked NF and MSCM-coated NF. ( 3 ) Biodistribution of MSCM-NF/LNP-Cas9 after injection into the bone marrow of right tibia indicates prolonged localization in tibia when compared with LNP-Cas9. ( 4 ) Leukemia stem cells exhibit reduced colony formation after treatment with therapeutic MSCM-NF/LNP-Cas9. **** p < 0.0001. Adapted from . Copyright © 2021, The Author(s) under CCBY 4.0 license.

Journal: International Journal of Molecular Sciences

Article Title: Nanofiber Carriers of Therapeutic Load: Current Trends

doi: 10.3390/ijms23158581

Figure Lengend Snippet: Injectable biomimetic nanofiber formulation for acute myeloid leukemia treatment: ( 1 ) PCL nanofibril coated with mesenchymal stem cell membrane (MSCM) loaded with cytokine CXCL12α and lipid nanoparticles-CRISPR/Cas9 (LNP-Cas9) complex. ( 2 ) Images of naked NF and MSCM-coated NF. ( 3 ) Biodistribution of MSCM-NF/LNP-Cas9 after injection into the bone marrow of right tibia indicates prolonged localization in tibia when compared with LNP-Cas9. ( 4 ) Leukemia stem cells exhibit reduced colony formation after treatment with therapeutic MSCM-NF/LNP-Cas9. **** p < 0.0001. Adapted from . Copyright © 2021, The Author(s) under CCBY 4.0 license.

Article Snippet: PCL , LNPs loaded with CRISPR-Cas9 RNP complex , Biomimetic MSCM coating CXCL12 chimokine , Single nozzle electrospinning , Fragmented nanofibrils with biomimetic coating , Intra bone-marrow injection , Reduced human leukemic burden in mice , [ ] .

Techniques: Formulation, Membrane, CRISPR, Injection

The relationship between relative expression of apoptotic genes and days of luxation ( BAX , Bcl-2-associated X protein; BCL-2 , B-cell lymphoma-2; CAS-3 cysteine aspartate-specific protease-3; CAS-9 , cysteine aspartate-specific protease-9).

Journal: Veterinary Medicine International

Article Title: Articular Cartilage Gene Expression after Coxofemoral Joint Luxation in the Dog

doi: 10.1155/2013/936317

Figure Lengend Snippet: The relationship between relative expression of apoptotic genes and days of luxation ( BAX , Bcl-2-associated X protein; BCL-2 , B-cell lymphoma-2; CAS-3 cysteine aspartate-specific protease-3; CAS-9 , cysteine aspartate-specific protease-9).

Article Snippet: Quantification of ten transcripts—aggrecan ( AGG ); type II collagen, alpha-1 chain ( COL2A1 ); matrix metalloproteinase-3 ( MMP-3 ); hyaluronan synthase-1 ( HAS-1 ); hyaluronan synthase-2 ( HAS-2 ); tissue inhibitor of metalloproteinase-1 ( TIMP-1 ); Bcl-2-associated X protein ( BAX ); B-cell lymphoma-2 ( BCL-2 ); cysteine aspartate-specific protease-3 ( CAS-3 ); and cysteine aspartate-specific protease-9 ( CAS-9 ) (Shanghai BlueGene Biotech, Shanghai, China)—was performed for all samples.

Techniques: Expressing